Why Neil Woodford could be right to avoid these FTSE 250 dividend stocks

Roland Head takes a look at two successful FTSE 250 (INDEXFTSE:MCX) UK-focused dividend stocks shunned by Neil Woodford.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Investing successfully isn’t just about picking winners. It’s just as important to avoid losing stocks, as these can crush your portfolio’s profits.

Today I’m going to look at two successful UK dividend stocks. Both have been shunned by one of the UK’s most high-profile fund managers, Neil Woodford. Is he right to avoid these businesses?

Another impressive quarter

Motor insurance firm Hastings Group (LSE: HSTG) has been one of the most successful flotations in recent years, reporting eight successive quarters of growth since its IPO. The shares have also doubled in that time.

Today’s third-quarter update suggests that momentum remains strong. Hastings had 2.6m live customer policies at the end of September, a 14% increase on the same time last year.

Despite this aggressive expansion, the firm doesn’t seem to have sacrificed any pricing power. Gross written premiums rose by 25% to £714m during the first nine months of 2017, compared to the same period last year.

Too good to be true?

How can Hastings grow so rapidly during a period when some rivals have delivered much flatter performances? The company’s financial strength and profitability seem very similar to rivals such as Direct Line Insurance Group. I don’t know enough about insurance to dig very deeply into the group’s business model, so I can’t answer this question.

What I can say is that the shares still seem reasonably priced. Hastings’ stock trades on a 2017 forecast P/E of 15, with a prospective yield of 4%. Forecast earnings growth of 16% in 2018 means that these figures improve to a P/E of 12.9 and a yield of 4.6% next year.

I plan to continue holding my shares, but I’m unsure about buying more.

I’m with Woodford on this one

At the end of September, Neil Woodford’s high-yield Income Focus Fund owned shares of no fewer than seven UK housebuilding stocks. So why is he avoiding one of the UK’s most profitable businesses in the sector, Berkeley Group Holdings (LSE: BKG)?

One reason may be that Berkeley’s focus on high-end London housing means it’s particularly exposed to the current slowdown in the capital.

A second reason might be that just one month ago, Berkeley’s two most senior directors sold £44m of their families’ holdings in the firm. Although founder Tony Pidgley and chief executive Rob Perrins still have hefty shareholdings, I see such a big sale as a sign that the good times could be coming to an end.

That’s certainly my reading of Berkeley’s trading commentary this year. The group had forward sales totalling £2.74bn at the end of April, and estimated future gross profits from its land bank of £6.4bn.

However, the company’s trading statement in September suggested to me that it’s scaling back new projects, and focusing on converting some of its book value into cash.

The recent use of share buybacks is also a warning flag, in my view. With the stock at record highs, buybacks don’t necessarily offer good value. But they do help to support EPS, and the share price.

Berkeley’s earnings per share is expected to fall by around 28% next year. I’m not sure that the promise of a 5% yield is enough to make them a buy, so I’ll be staying away for now.

Roland Head owns shares of Hastings Group. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »